Heparins, antivitamins K. Principles and rules of use. Posology of non-fractionated heparins
Delsart, D.; Chambefort, V.; Decousus, H.
La Revue du Praticien 51(13): 1489-1497
2001
ISSN/ISBN: 0035-2640 PMID: 11601082 Document Number: 528303
Document emailed within 1 workday
Related Documents
Mismetti, P.; Decousus, H. 1995: Anticoagulants. Antivitamins K: principles and rules of use, posology La Revue du Praticien 45(8): 1014-1017Pelouze, G.A. 1994: Fractionated heparins: LMWH or LMMH? Presse Medicale 23(26): 1223
Gavrishina, E.V.; Dobrovolskii, A.V.; Niyazov, R.R.; Romodanovskii, D.P.; Vasil'ev, A.N. 2015: Good Planning Practice in Preclinical and Clinical Studies of Unfractionated and Fractionated Heparins in Russia as the Basis of Safe and Effective Anticoagulation Therapy Eksperimental'naia i Klinicheskaia Farmakologiia 78(11): 15-20
Cohen, P.; Guillevin, L. 1993: Corticosteroids. Principles and rules of their use, posology La Revue du Praticien 43(2): 247-250
Bonnetblanc, J.M. 1992: Corticosteroids: topical cutaneous. Principles and rules of use, posology La Revue du Praticien 42(20): 2609-2613
Eschalier, A.; Picard, P.; Dubray, C. 2000: Analgesics. Utilization principles and rules, posology of morphine and its derivatives La Revue du Praticien 50(8): 907-915
Samama, M. 1986: The new heparins Presse Medicale 15(32): 1631-1635
Rosocha, S.; Schmitz-Huebner, U. 1994: Low-molecular heparins Deutsche Medizinische Wochenschrift 119(18): 678
Linda M. Hiebert 2002: Oral Heparins Clinical Laboratory 48(3-4): 111-116
Thies, H.A.; Gins, R.; Kuder, E. 1976: Subcutaneous heparins Die Medizinische Welt 27(46): 2240-2241
Drouet, L. 1993: Low molecular weight heparins Presse Medicale 22(40): 2002-2008
Fareed, J.; Hoppensteadt, D.; Jeske, W.; Clarizio, R.; Walenga, J.M. 1998: Low molecular weight heparins: are they different? Canadian Journal of Cardiology 14 Suppl E: 28e-34e
Ebell, M.H. 1994: Low molecular weight heparins for DVT Journal of Family Practice 39(5): 501-502
Agnelli, G.; Cosmi, B. 1990: Low molecular weight heparins Medicina 10(1): 9-15
Doutremepuich, C.; Puyal, C.; Lalanne, M.C.; Doutremepuich, F.; De Sèze, O. 1990: How to standardize low molecular weight heparins Annales de Biologie Clinique 48(4): 221-225
Horellou, M.H.; Samama, M. 1991: Low molecular weight heparins in everyday practice Journal des Maladies Vasculaires 16(2): 179-183
Vignes, S.; Meyer, G.; Marjanovic, Z.; Farge-Bancel, D. 1997: Current indications of low-molecular-weight heparins Annales de Medecine Interne 148(2): 154-162
Samama, M.M.; Michaut-Paterno, F. 1991: Therapeutic indications of low molecular weight heparins Archives des Maladies du Coeur et des Vaisseaux 84(11 Suppl): 1733-1743
Gallimore, M.J.; Heller, W.; Fuhrer, G.; Wendel, H.; Klaffschenkel, R.; Hoffmeister, H.E. 1993: Contact activation, heparins and cardiopulmonary bypass Thrombosis and Haemostasis 69(1): 92-93
Mammen, E.F.; Arcelus, J.; Messmore, H.; Altman, R.; Nurmohamed, M.; Eldor, A. 1999: Clinical differentiation of low molecular weight heparins Seminars in Thrombosis and Hemostasis 25(Suppl 3): 135-144